ST開元(300338.SZ):擬向麓元能材增資1100萬元
格隆匯11月14日丨ST開元(300338.SZ)公佈,基於公司發展規劃和業務發展需求,結合公司實際情況,開元教育科技集團股份有限公司於2022年11月14日召開了第四屆董事會第三十四次會議,審議通過了《關於擬向全資子公司增資的議案》,同意使用自有資金向公司全資子公司長沙麓元能材科技有限公司(簡稱“子公司”或“麓元能材”)增資人民幣1100萬元,同時授權公司管理層具體辦理與此次增資有關的後續事項。此次增資完成後,麓元能材的註冊資本將由人民幣100萬元變更為人民幣1200萬元,公司仍持有其100%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.